TY - JOUR
T1 - The Surviving Sepsis Campaign
T2 - Research Priorities for Coronavirus Disease 2019 in Critical Illness
AU - Coopersmith, Craig M.
AU - Antonelli, Massimo
AU - Bauer, Seth R.
AU - Deutschman, Clifford S.
AU - Evans, Laura E.
AU - Ferrer, Ricard
AU - Hellman, Judith
AU - Jog, Sameer
AU - Kesecioglu, Jozef
AU - Kissoon, Niranjan
AU - Martin-Loeches, Ignacio
AU - Nunnally, Mark E.
AU - Prescott, Hallie C.
AU - Rhodes, Andrew
AU - Talmor, Daniel
AU - Tissieres, Pierre
AU - De Backer, Daniel
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021
Y1 - 2021
N2 - OBJECTIVES: To identify research priorities in the management, pathophysiology, and host response of coronavirus disease 2019 in critically ill patients. DESIGN: The Surviving Sepsis Research Committee, a multiprofessional group of 17 international experts representing the European Society of Intensive Care Medicine and Society of Critical Care Medicine, was virtually convened during the coronavirus disease 2019 pandemic. The committee iteratively developed the recommendations and subsequent document. METHODS: Each committee member submitted a list of what they believed were the most important priorities for coronavirus disease 2019 research. The entire committee voted on 58 submitted questions to determine top priorities for coronavirus disease 2019 research. RESULTS: The Surviving Sepsis Research Committee provides 13 priorities for coronavirus disease 2019. Of these, the top six priorities were identified and include the following questions: 1) Should the approach to ventilator management differ from the standard approach in patients with acute hypoxic respiratory failure?, 2) Can the host response be modulated for therapeutic benefit?, 3) What specific cells are directly targeted by severe acute respiratory syndrome coronavirus 2, and how do these cells respond?, 4) Can early data be used to predict outcomes of coronavirus disease 2019 and, by extension, to guide therapies?, 5) What is the role of prone positioning and noninvasive ventilation in nonventilated patients with coronavirus disease?, and 6) Which interventions are best to use for viral load modulation and when should they be given? CONCLUSIONS: Although knowledge of both biology and treatment has increased exponentially in the first year of the coronavirus disease 2019 pandemic, significant knowledge gaps remain. The research priorities identified represent a roadmap for investigation in coronavirus disease 2019.
AB - OBJECTIVES: To identify research priorities in the management, pathophysiology, and host response of coronavirus disease 2019 in critically ill patients. DESIGN: The Surviving Sepsis Research Committee, a multiprofessional group of 17 international experts representing the European Society of Intensive Care Medicine and Society of Critical Care Medicine, was virtually convened during the coronavirus disease 2019 pandemic. The committee iteratively developed the recommendations and subsequent document. METHODS: Each committee member submitted a list of what they believed were the most important priorities for coronavirus disease 2019 research. The entire committee voted on 58 submitted questions to determine top priorities for coronavirus disease 2019 research. RESULTS: The Surviving Sepsis Research Committee provides 13 priorities for coronavirus disease 2019. Of these, the top six priorities were identified and include the following questions: 1) Should the approach to ventilator management differ from the standard approach in patients with acute hypoxic respiratory failure?, 2) Can the host response be modulated for therapeutic benefit?, 3) What specific cells are directly targeted by severe acute respiratory syndrome coronavirus 2, and how do these cells respond?, 4) Can early data be used to predict outcomes of coronavirus disease 2019 and, by extension, to guide therapies?, 5) What is the role of prone positioning and noninvasive ventilation in nonventilated patients with coronavirus disease?, and 6) Which interventions are best to use for viral load modulation and when should they be given? CONCLUSIONS: Although knowledge of both biology and treatment has increased exponentially in the first year of the coronavirus disease 2019 pandemic, significant knowledge gaps remain. The research priorities identified represent a roadmap for investigation in coronavirus disease 2019.
KW - coronavirus disease 2019
KW - critical illness
KW - intensive care unit
KW - priorities
KW - research
KW - Surviving Sepsis Campaign
UR - http://www.scopus.com/inward/record.url?scp=85103228622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103228622&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000004895
DO - 10.1097/CCM.0000000000004895
M3 - Article
C2 - 33591008
AN - SCOPUS:85103228622
SN - 0090-3493
SP - 598
EP - 622
JO - Critical Care Medicine
JF - Critical Care Medicine
ER -